Ligand Pharmaceuticals Incorporated Revenue 2009–2025
Ligand Pharmaceuticals Incorporated reported $268.09M of revenue for fiscal 2025. That was 60.4% higher than fiscal 2024. Compared with fiscal 2020, the change was +63.9%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $268.09M | +60.4% |
| FY 2024 | $167.13M | +27.3% |
| FY 2023 | $131.31M | -33.1% |
| FY 2022 | $196.25M | -18.8% |
| FY 2021 | $241.54M | +47.7% |
| FY 2020 | $163.56M | +36.0% |
| FY 2019 | $120.28M | -52.2% |
| FY 2018 | $251.45M | +78.2% |
| FY 2017 | $141.10M | +29.5% |
| FY 2016 | $108.97M | +51.5% |
| FY 2015 | $71.91M | +11.4% |
| FY 2014 | $64.54M | +31.8% |
| FY 2013 | $48.97M | +56.0% |
| FY 2012 | $31.39M | +4.5% |
| FY 2011 | $30.04M | +27.6% |
| FY 2010 | $23.54M | -39.6% |
| FY 2009 | $38.94M | — |
Source: Ligand Pharmaceuticals Incorporated SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open LGND 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Ligand Pharmaceuticals Incorporated reported $268.09M of revenue for fiscal 2025. That was 60.4% higher than fiscal 2024. Compared with fiscal 2020, the change was +63.9%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Ligand Pharmaceuticals Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeLigand Pharmaceuticals Incorporated — frequently asked questions
What is Ligand Pharmaceuticals Incorporated's revenue?
Ligand Pharmaceuticals Incorporated (LGND) reported revenue of $268.09M for fiscal year 2025, per its SEC filings.
How has Ligand Pharmaceuticals Incorporated's revenue changed over time?
Between fiscal 2009 and 2025, LGND's revenue grew at roughly 12.8% per year (compound annual rate), from $38.94M to $268.09M.
Where does this data come from?
Figures are computed from Ligand Pharmaceuticals Incorporated's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.